MEDICARE PART B
Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015
Business & Finance, Accounting, Governmental
| Author: | Hugues Dumont | ISBN: | 1230002137964 |
| Publisher: | Hugues DUMONT | Publication: | February 3, 2018 |
| Imprint: | Language: | English |
| Author: | Hugues Dumont |
| ISBN: | 1230002137964 |
| Publisher: | Hugues DUMONT |
| Publication: | February 3, 2018 |
| Imprint: | |
| Language: | English |
In 2015, Medicare spent about $26 billion on Part B drugs, including injectable drugs, and certain cancer drugs, which are typically administered in a physician's office or hospital outpatient department. GAO was asked to examine Medicare's share of the Part B drug market. This report describes Medicare's market share for high-expenditure Part B drugs paid based on ASP and the characteristics of those drugs...
In 2015, Medicare spent about $26 billion on Part B drugs, including injectable drugs, and certain cancer drugs, which are typically administered in a physician's office or hospital outpatient department. GAO was asked to examine Medicare's share of the Part B drug market. This report describes Medicare's market share for high-expenditure Part B drugs paid based on ASP and the characteristics of those drugs...
